PARP-Targeted Auger Therapy in p53 Mutant Colon Cancer Xenograft Mouse Models-Reference-Cited by-同舟云学术

PARP-Targeted Auger Therapy in p53 Mutant Colon Cancer Xenograft Mouse Models

Published:2021-07-28 Issue:9 Volume:18 Page:3418-3428
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Wilson Thomas¹,Pirovano Giacomo¹,Xiao Gu²,Samuels Zachary¹,Roberts Sheryl¹^ORCID,Viray Tara¹,Guru Navjot¹,Zanzonico Pat¹,Gollub Marc¹³,Pillarsetty Naga Vara Kishore¹³,Reiner Thomas¹³⁴^ORCID,Bargonetti Jill²⁵⁶^ORCID

Affiliation:

1. Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, United States

2. Department of Biological Sciences Hunter College, City University of New York, New York, New York 10065, United States

3. Department of Radiology, Weill Cornell Medical College, New York, New York 10065, United States

4. Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States

5. The Graduate Center Biology and Biochemistry PhD Program of City University of New York, New York, New York 10016, United States

6. Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, New York 10065, United States

Funder

National Cancer Institute

Breast Cancer Research Foundation

Memorial Sloan Kettering Imaging and Radiation Sciences Program

Theragnostics, Inc

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.1c00323

Reference37 articles.

1. Radiopharmaceutical therapy in cancer: clinical advances and challenges

2. Radiotheranostics: a roadmap for future development

3. α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 2

4. α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 1

5. Auger electrons for cancer therapy – a review

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PARP inhibitor resistance mechanisms and PARP inhibitor derived imaging probes;Expert Review of Anticancer Therapy;2024-09-03

2. Quinazoline-2,4(1 H,3 H)-dione Scaffold for development of a novel PARP-targeting PET probe for tumor imaging;European Journal of Nuclear Medicine and Molecular Imaging;2024-07-16

3. Preparation and Evaluation of a Novel ^99mTc-Labeled Niraparib Isonitrile Complex as a Potential PARP-1 Imaging Agent;Molecular Pharmaceutics;2024-06-06

4. Advances in Radioligand Theranostics in Oncology;Molecular Diagnosis & Therapy;2024-03-31

5. Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment;Cancer Letters;2024-03